Malta (National level) (MT)

Regional Innovation Performance (2019) Moderate

Total population (2019) 493559

Population per km² (2017) 1495

Proportion population older 65 year % 18,68%

Malta, officially known as the Republic of Malta, is a Southern European island country consisting of an archipelago in the Mediterranean Sea. It has a population of 417,520.

 

The country's S3 priorities in the area of health have a focus on healthy living and active ageing, and e-health. In Malta the life sciences sector has a wide ranging presence in the Maltese economy, with well established operations in the manufacture of pharmaceuticals and medical devices, the production of software for the healthcare industry, as well as a growing health tourism sector. All this has been boosted by the country’s workforce as well as effective connectivity with foreign markets.


Healthprofile according to the European Observatory on Health Systems and Policies and the Organisation for Economic Co-operation and Development (OECD):


Malta’s population enjoys generally good health and one of the longest life expectancies in the EU. Nevertheless, high obesity rates among adults and adolescents pose a serious threat to public health. The National Health Service provides universal coverage for a comprehensive benefit package, while the private sector plays a key role in the delivery of primary care. Strengthening primary care to improve efficiency and better serve those living with chronic conditions is an important policy goal.



Membership status


Member ICPerMed? no 

Mountain ? Non-mountain

Member Euregha? no 

Adriatic-Ionian MacroRegion? no

InnoStars Region? no 

Northern Sparsely Populated Area (NSPA)? no

PM region according EC? no 

Baltic Sea MacroRegion? no

S3MedTech region? no 

Danube MacroRegion? no

S3P4PM region? no 

Alpine MacroRegion? no

Regions4PM region? no

S3ClusSport member? no 

Central Europe? no

MedTech4Europe? no

Council of European BioRegions (CEBR)? no

1M+Genome initiative? member

European Regions Research & Innovation Network(ERRIN)?  yes

Vanguard Initiative? no

ERAPerMed?  no

Policy documents



NACE Personalised Medicine/Personalised Health related to Research and Innovation objectives:

Q.86 - Human health activities; M.72 - Scientific research and development.


Scientific domain NABS Personalised   Medicine/Personalised Health related to Research and Innovation: NABS07 - Health; NABS13 - General advancement of   knowledge: R&D financed from other sources than GUF; NABS99 - Total R&D appropriations.


Policy objective Personalised   Medicine/Personalised Health related related to Research and Innovation objectives: D.27 - e-Health (e.g. healthy ageing); G.46 - Ageing   societies; G.49 - Public health & well-being.

Policy document (RIS3): Yes

Policy document PM@RIS3: Yes - Health with a focus on healthy living and active ageing

Major initiatives


  1. myHealth Portal

  2. National Cancer Platform

  3. SNOMED National Release Centre Malta

  4. National Open EHR

  5. Better Care Platform 

  6. ITAMA: ICT Tools for the diagnosis of autoimmune disease in the Mediterranean area 

  7. Malta Life Sciences Park an international class facility for life sciences and information technology development 

  8. University of Malta, Department of Applied Biomedical Science, within the Faculty of Health Sciences Teaching and conduction/participation in research programmes 

  9. Centre for Molecular Medicine and Biobanking Teaching and conduction/participation in research programmes 

  10. Department of Physiology & Biochemistry, Faculty of Medicine and Surgery, Univ. of Malta Teaching and conduction/participation in research programmes 

  11. Italia Malta Genome Breast Cancer Cross Border Risk Surveillance 

  12. Member European '1+ Million Genomes' Initiative 

  13. Malta Biobank 

  14. MALTA CONGENITAL ANOMALIES REGISTRY (MCAR) - it contributes to EUROCAT 


Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?


  1. ERDF 8.139 - The Setting Up of the Establishment for Blood, Tissue and Cell Centre (recently awarded)  No website available yet


Self evaluation


General perception of the implementation level of PM in the region - Low

Rate of the need for developing and implementing PM in the region - High

Rate of the need for increasing support/funding for PM activities in the  region - High

Rate of the need for increasing the capacity of PM skills in the region - Very High

Rate of the genomics literacy of the citizens in the region - Low

Rate of the need for increasing interregional collaboration in PM - High

Image attribution

By NuclearVacuum - File:Location European nation states.svgThis W3C-unspecified vector image was created with Inkscape., CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=8105216

Picture2.png
SHAPIRE SOCIAL ICONS-3.jpg
SHAPIRE SOCIAL ICONS-2.jpg
SHAPIRE SOCIAL ICONS-4.jpg

This project has received funding from the European Union’s Horizon 

2020 research and innovation programme under grant agreement No 825046

The project is co-ordinated by Department Economy, Science and Innovation (EWI) of the Flemish Government.

Department Economy, Science and Innovation - Koning Albert II-laan 35 1030 Brussels, Belgium